| Product Code: ETC7906514 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Latvia continued to see a steady increase in import shipments of buccal drug delivery products, with Lithuania, Netherlands, Switzerland, Poland, and Germany emerging as the top exporting countries. Despite the growth, the market remained relatively competitive with a low Herfindahl-Hirschman Index (HHI) indicating low concentration. The compound annual growth rate (CAGR) from 2020 to 2024 stood at a promising 8.6%, with a notable growth rate of 7.03% from 2023 to 2024, suggesting a positive trajectory for the market in the coming years.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Buccal Drug Delivery Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Buccal Drug Delivery Market Revenues & Volume, 2022 & 2032F |
3.3 Latvia Buccal Drug Delivery Market - Industry Life Cycle |
3.4 Latvia Buccal Drug Delivery Market - Porter's Five Forces |
3.5 Latvia Buccal Drug Delivery Market Revenues & Volume Share, By Indication, 2022 & 2032F |
3.6 Latvia Buccal Drug Delivery Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.7 Latvia Buccal Drug Delivery Market Revenues & Volume Share, By Design, 2022 & 2032F |
3.8 Latvia Buccal Drug Delivery Market Revenues & Volume Share, By Forms, 2022 & 2032F |
3.9 Latvia Buccal Drug Delivery Market Revenues & Volume Share, By Drugs, 2022 & 2032F |
3.10 Latvia Buccal Drug Delivery Market Revenues & Volume Share, By End-Users, 2022 & 2032F |
4 Latvia Buccal Drug Delivery Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring long-term drug delivery solutions |
4.2.2 Growing demand for non-invasive drug delivery methods |
4.2.3 Technological advancements in buccal drug delivery systems |
4.3 Market Restraints |
4.3.1 Regulatory hurdles in drug approval processes for buccal delivery systems |
4.3.2 Limited awareness and adoption of buccal drug delivery among healthcare professionals |
4.3.3 Concerns regarding the safety and efficacy of buccal drug delivery systems |
5 Latvia Buccal Drug Delivery Market Trends |
6 Latvia Buccal Drug Delivery Market, By Types |
6.1 Latvia Buccal Drug Delivery Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Latvia Buccal Drug Delivery Market Revenues & Volume, By Indication, 2022 - 2032F |
6.1.3 Latvia Buccal Drug Delivery Market Revenues & Volume, By Pain Management, 2022 - 2032F |
6.1.4 Latvia Buccal Drug Delivery Market Revenues & Volume, By Smoking Cessation, 2022 - 2032F |
6.1.5 Latvia Buccal Drug Delivery Market Revenues & Volume, By Angina Pectoris, 2022 - 2032F |
6.1.6 Latvia Buccal Drug Delivery Market Revenues & Volume, By Cough, 2022 - 2032F |
6.2 Latvia Buccal Drug Delivery Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Latvia Buccal Drug Delivery Market Revenues & Volume, By Non-Attached Drug Delivery Systems, 2022 - 2032F |
6.2.3 Latvia Buccal Drug Delivery Market Revenues & Volume, By Bio-Adhesive Drug Delivery Systems, 2022 - 2032F |
6.3 Latvia Buccal Drug Delivery Market, By Design |
6.3.1 Overview and Analysis |
6.3.2 Latvia Buccal Drug Delivery Market Revenues & Volume, By Matrix Type, 2022 - 2032F |
6.3.3 Latvia Buccal Drug Delivery Market Revenues & Volume, By Reserviour Type, 2022 - 2032F |
6.4 Latvia Buccal Drug Delivery Market, By Forms |
6.4.1 Overview and Analysis |
6.4.2 Latvia Buccal Drug Delivery Market Revenues & Volume, By Solid Buccal Adhesive Dosage Forms, 2022 - 2032F |
6.4.3 Latvia Buccal Drug Delivery Market Revenues & Volume, By Buccal tablets, 2022 - 2032F |
6.4.4 Latvia Buccal Drug Delivery Market Revenues & Volume, By Wafers, 2022 - 2032F |
6.4.5 Latvia Buccal Drug Delivery Market Revenues & Volume, By Lozenges, 2022 - 2032F |
6.4.6 Latvia Buccal Drug Delivery Market Revenues & Volume, By Semi-Solid Buccal Adhesive Dosage Forms, 2022 - 2032F |
6.4.7 Latvia Buccal Drug Delivery Market Revenues & Volume, By Gels, 2022 - 2032F |
6.5 Latvia Buccal Drug Delivery Market, By Drugs |
6.5.1 Overview and Analysis |
6.5.2 Latvia Buccal Drug Delivery Market Revenues & Volume, By Oral Bioadhesive Formulation, 2022 - 2032F |
6.5.3 Latvia Buccal Drug Delivery Market Revenues & Volume, By Hydrocartisone succinate, 2022 - 2032F |
6.5.4 Latvia Buccal Drug Delivery Market Revenues & Volume, By Hypromellose, 2022 - 2032F |
6.5.5 Latvia Buccal Drug Delivery Market Revenues & Volume, By Miconazole, 2022 - 2032F |
6.5.6 Latvia Buccal Drug Delivery Market Revenues & Volume, By Chlorohexidine, 2022 - 2032F |
6.5.7 Latvia Buccal Drug Delivery Market Revenues & Volume, By Sublingual Formulation, 2022 - 2032F |
6.6 Latvia Buccal Drug Delivery Market, By End-Users |
6.6.1 Overview and Analysis |
6.6.2 Latvia Buccal Drug Delivery Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.6.3 Latvia Buccal Drug Delivery Market Revenues & Volume, By Homecare, 2022 - 2032F |
6.6.4 Latvia Buccal Drug Delivery Market Revenues & Volume, By Specialty Clinics, 2022 - 2032F |
7 Latvia Buccal Drug Delivery Market Import-Export Trade Statistics |
7.1 Latvia Buccal Drug Delivery Market Export to Major Countries |
7.2 Latvia Buccal Drug Delivery Market Imports from Major Countries |
8 Latvia Buccal Drug Delivery Market Key Performance Indicators |
8.1 Patient adherence rates to buccal drug delivery systems |
8.2 Number of clinical trials and research studies on buccal drug delivery in Latvia |
8.3 Rate of adoption of buccal drug delivery by pharmaceutical companies |
9 Latvia Buccal Drug Delivery Market - Opportunity Assessment |
9.1 Latvia Buccal Drug Delivery Market Opportunity Assessment, By Indication, 2022 & 2032F |
9.2 Latvia Buccal Drug Delivery Market Opportunity Assessment, By Type, 2022 & 2032F |
9.3 Latvia Buccal Drug Delivery Market Opportunity Assessment, By Design, 2022 & 2032F |
9.4 Latvia Buccal Drug Delivery Market Opportunity Assessment, By Forms, 2022 & 2032F |
9.5 Latvia Buccal Drug Delivery Market Opportunity Assessment, By Drugs, 2022 & 2032F |
9.6 Latvia Buccal Drug Delivery Market Opportunity Assessment, By End-Users, 2022 & 2032F |
10 Latvia Buccal Drug Delivery Market - Competitive Landscape |
10.1 Latvia Buccal Drug Delivery Market Revenue Share, By Companies, 2025 |
10.2 Latvia Buccal Drug Delivery Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here